This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. APT, MLSS, LGMK, ITOS, VIGL, SENS, TMCI, RIGL, RCKT, and ATXSShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), iTeos Therapeutics (ITOS), Vigil Neuroscience (VIGL), Senseonics (SENS), Treace Medical Concepts (TMCI), Rigel Pharmaceuticals (RIGL), Rocket Pharmaceuticals (RCKT), and Astria Therapeutics (ATXS). Histogenics vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark iTeos Therapeutics Vigil Neuroscience Senseonics Treace Medical Concepts Rigel Pharmaceuticals Rocket Pharmaceuticals Astria Therapeutics Histogenics (NASDAQ:HSGX) and Alpha Pro Tech (NYSE:APT) are both small-cap surgical appliances & supplies industry companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations. Is HSGX or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Histogenics' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets HistogenicsN/A -34.96% 18.40% Alpha Pro Tech 6.99%6.70%5.76% Do institutionals and insiders have more ownership in HSGX or APT? 40.4% of Histogenics shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 19.7% of Histogenics shares are owned by insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, HSGX or APT? Alpha Pro Tech has higher revenue and earnings than Histogenics. Histogenics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogenicsN/AN/A-$8.64M-$0.79-1.26Alpha Pro Tech$58.18M0.90$4.19M$0.3713.05 Does the media refer more to HSGX or APT? In the previous week, Alpha Pro Tech had 1 more articles in the media than Histogenics. MarketBeat recorded 1 mentions for Alpha Pro Tech and 0 mentions for Histogenics. Alpha Pro Tech's average media sentiment score of 0.67 beat Histogenics' score of 0.00 indicating that Alpha Pro Tech is being referred to more favorably in the news media. Company Overall Sentiment Histogenics Neutral Alpha Pro Tech Positive Which has more volatility and risk, HSGX or APT? Histogenics has a beta of 3.1, indicating that its share price is 210% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. SummaryAlpha Pro Tech beats Histogenics on 8 of the 12 factors compared between the two stocks. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$93.99M$25.01M$5.53B$9.36BDividend YieldN/AN/A4.74%4.14%P/E Ratio-1.2613.0528.9523.77Price / SalesN/A1.71443.4197.24Price / CashN/A12.8024.4827.20Price / Book-99.361.618.365.61Net Income-$8.64M-$5.31M$3.25B$265.26M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.99-3.5%N/A-18.9%$93.99MN/A-1.2649Gap DownAPTAlpha Pro Tech2.0287 of 5 stars$4.85+2.1%N/A-11.2%$52.69M$58.18M13.11120News CoverageMLSSMilestone Scientific2.0219 of 5 stars$0.65+1.4%$1.25+92.3%-54.2%$51.01M$8.61M-9.2830News CoverageLGMKLogicMark0.8045 of 5 stars$0.00flatN/A-99.9%$1.96M$9.88M0.0020Gap UpITOSiTeos Therapeutics3.0409 of 5 stars$10.120.0%$15.64+54.7%-39.1%$387.10M$35M-3.3390Upcoming EarningsVIGLVigil Neuroscience3.1624 of 5 stars$8.08+0.2%$10.80+33.7%+103.8%$385.10MN/A-3.9440News CoverageShort Interest ↑SENSSenseonics1.7701 of 5 stars$0.59+0.9%$1.55+165.0%+25.3%$382.72M$23.68M-4.5090TMCITreace Medical Concepts2.3426 of 5 stars$6.06+2.9%$10.52+73.5%-19.1%$381.11M$209.36M-7.13250Positive NewsUpcoming EarningsRIGLRigel Pharmaceuticals3.3023 of 5 stars$21.22+5.8%$36.40+71.6%+125.9%$379.21M$203.08M10.25160Upcoming EarningsRCKTRocket Pharmaceuticals4.8353 of 5 stars$3.52+4.4%$18.60+428.9%-85.7%$373.23MN/A-1.33240Trending NewsATXSAstria Therapeutics2.3914 of 5 stars$6.62+3.1%$30.00+353.2%-37.2%$373.17MN/A-3.5430Upcoming Earnings Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors ITOS Competitors VIGL Competitors SENS Competitors TMCI Competitors RIGL Competitors RCKT Competitors ATXS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSGX Stock Alerts